1. Home
  2. CABA vs TCX Comparison

CABA vs TCX Comparison

Compare CABA & TCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cabaletta Bio Inc.

CABA

Cabaletta Bio Inc.

HOLD

Current Price

$2.41

Market Cap

227.2M

Sector

Health Care

ML Signal

HOLD

Logo Tucows Inc.

TCX

Tucows Inc.

HOLD

Current Price

$23.11

Market Cap

233.3M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CABA
TCX
Founded
2017
1992
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
227.2M
233.3M
IPO Year
2019
1996

Fundamental Metrics

Financial Performance
Metric
CABA
TCX
Price
$2.41
$23.11
Analyst Decision
Strong Buy
Analyst Count
8
0
Target Price
$13.50
N/A
AVG Volume (30 Days)
2.2M
28.6K
Earning Date
11-10-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$384,728,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
8.03
52 Week Low
$0.99
$13.27
52 Week High
$3.67
$23.38

Technical Indicators

Market Signals
Indicator
CABA
TCX
Relative Strength Index (RSI) 50.80 62.72
Support Level $2.32 $21.88
Resistance Level $2.48 $23.00
Average True Range (ATR) 0.14 0.89
MACD 0.00 0.11
Stochastic Oscillator 31.58 100.00

Price Performance

Historical Comparison
CABA
TCX

About CABA Cabaletta Bio Inc.

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies: CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) that have the potential to be applied across a broad range of autoimmune diseases.

About TCX Tucows Inc.

Tucows Inc is a corporate parent, allocating capital and providing efficient shared services to its three businesses. The Company offers Mobile Service Enabler (MSE) solutions, as well as professional services to other retail mobile providers. The Company is also a distributor of Internet services, including domain name registration, digital certificates, and email. It provides these services through an Internet-based distribution network of Internet Service Providers, web hosting companies, and other providers of Internet services to end-users. It operates in three segments: Ting, Wavelo, and Tucows Domains. It generates the majority of its revenue from Tucows Domains. Geographically company operates in USA, Canada and Europe.

Share on Social Networks: